Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy
2009 ◽
Vol 18
(9)
◽
pp. 1171-1177
◽
Keyword(s):
2006 ◽
Vol 14
(4)
◽
pp. 354-360
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. e19536-e19536
Keyword(s):
2012 ◽
Vol 21
(2)
◽
pp. 565-573
◽
Keyword(s):
2011 ◽
Vol 47
◽
pp. S239
◽
Keyword(s):
2017 ◽
Vol 51
(9)
◽
pp. 804-810
◽
Keyword(s):
2014 ◽
Vol 26
(12)
◽
pp. 1792-1801
◽
Keyword(s):
2017 ◽
Vol 32
(1)
◽
pp. 68-72
◽
Keyword(s):
Keyword(s):